1. Home
  2. LRMR vs FLL Comparison

LRMR vs FLL Comparison

Compare LRMR & FLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • FLL
  • Stock Information
  • Founded
  • LRMR N/A
  • FLL 1987
  • Country
  • LRMR United States
  • FLL United States
  • Employees
  • LRMR N/A
  • FLL N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • FLL Hotels/Resorts
  • Sector
  • LRMR Health Care
  • FLL Consumer Discretionary
  • Exchange
  • LRMR Nasdaq
  • FLL Nasdaq
  • Market Cap
  • LRMR 183.8M
  • FLL 116.4M
  • IPO Year
  • LRMR N/A
  • FLL 1993
  • Fundamental
  • Price
  • LRMR $2.24
  • FLL $3.30
  • Analyst Decision
  • LRMR Strong Buy
  • FLL Strong Buy
  • Analyst Count
  • LRMR 9
  • FLL 4
  • Target Price
  • LRMR $19.00
  • FLL $6.25
  • AVG Volume (30 Days)
  • LRMR 1.4M
  • FLL 165.3K
  • Earning Date
  • LRMR 04-30-2025
  • FLL 05-08-2025
  • Dividend Yield
  • LRMR N/A
  • FLL N/A
  • EPS Growth
  • LRMR N/A
  • FLL N/A
  • EPS
  • LRMR N/A
  • FLL N/A
  • Revenue
  • LRMR N/A
  • FLL $292,065,000.00
  • Revenue This Year
  • LRMR N/A
  • FLL $10.53
  • Revenue Next Year
  • LRMR N/A
  • FLL $7.53
  • P/E Ratio
  • LRMR N/A
  • FLL N/A
  • Revenue Growth
  • LRMR N/A
  • FLL 21.16
  • 52 Week Low
  • LRMR $1.61
  • FLL $2.86
  • 52 Week High
  • LRMR $11.20
  • FLL $5.90
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 47.46
  • FLL 47.55
  • Support Level
  • LRMR $2.03
  • FLL $3.06
  • Resistance Level
  • LRMR $3.07
  • FLL $3.40
  • Average True Range (ATR)
  • LRMR 0.30
  • FLL 0.24
  • MACD
  • LRMR 0.01
  • FLL 0.06
  • Stochastic Oscillator
  • LRMR 31.12
  • FLL 54.32

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About FLL Full House Resorts Inc.

Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.

Share on Social Networks: